LDHB Overexpression Can Partially Overcome T Cell Inhibition by Lactic Acid

Int J Mol Sci. 2022 May 26;23(11):5970. doi: 10.3390/ijms23115970.

Abstract

Accelerated glycolysis leads to secretion and accumulation of lactate and protons in the tumor environment and determines the efficacy of adoptive T cell and checkpoint inhibition therapy. Here, we analyzed effects of lactic acid on different human CD4 T cell subsets and aimed to increase CD4 T cell resistance towards lactic acid. In all CD4 T cell subsets analyzed, lactic acid inhibited metabolic activity (glycolysis and respiration), cytokine secretion, and cell proliferation. Overexpression of the lactate-metabolizing isoenzyme LDHB increased cell respiration and mitigated lactic acid effects on intracellular cytokine production. Strikingly, LDHB-overexpressing cells preferentially migrated into HCT116 tumor spheroids and displayed higher expression of cytotoxic effector molecules. We conclude, that LDHB overexpression might be a promising strategy to increase the efficacy of adoptive T cell transfer therapy.

Keywords: LDH; T cell metabolism; T cells; adoptive cell transfer; glycolysis; interferon gamma; lactate; lactic acid.

MeSH terms

  • Cell Line, Tumor
  • Cytokines / metabolism
  • Glycolysis
  • Humans
  • L-Lactate Dehydrogenase / genetics
  • L-Lactate Dehydrogenase / metabolism
  • Lactate Dehydrogenases / metabolism*
  • Lactic Acid* / metabolism
  • Neoplasms* / metabolism
  • T-Lymphocytes / metabolism

Substances

  • Cytokines
  • Lactic Acid
  • Lactate Dehydrogenases
  • L-Lactate Dehydrogenase
  • D-lactate dehydrogenase

Grants and funding

This research was funded by the Leibniz Institute for Immunotherapy and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Projektnummer 324392634—TRR 221.